Showing 1281-1290 of 1648 results for "".
- CollPlant Achieves Milestone in Dermal Filler Developmenthttps://modernaesthetics.com/news/collplant-achieves-milestone-in-dermal-filler-development/2473431/CollPlant Biotechnologies hit a milestone in the development of a regenerative dermal filler, and this achievement triggers a $10 million payment from AbbVie to CollPlant. In 2021, CollPlant and AbbVie entered into an exclusive worldwide development and commercializatio
- Xeomin Performs Well in Phase 3 Studies of Upper Facial Lineshttps://modernaesthetics.com/news/xeomin-performs-well-in-phase-3-studies-of-upper-facial-lines/2473428/Two pivotal phase 3 clinical studies demonstrated the efficacy and safety of Xeomin (incobotulinumtoxinA) in the simultaneous treatment of horizontal forehead lines, glabellar frown lines, and lateral canthal lines, according to Merz Aesthetics. Merz Aesthetics will submit these data as
- Botox Cosmetic Announces the Winners of the IFundWomen Grant Programhttps://modernaesthetics.com/news/botox-cosmetic-announces-the-winners-of-the-ifundwomen-grant-program/2473427/Twenty female entrepreneurs will receive funding and mentorship through Allergan’s BOTOX Cosmetic and IFundWomen grant program. "There were so many remarkable applications that featured thoughtful business solutions," says Carrie Strom, President, Global Aller
- Body Contouring Doesn't Increase Long-term Weight Loss after Bariatric Surgery: Studyhttps://modernaesthetics.com/news/body-contouring-doesnt-increase-long-term-weight-loss-after-bariatric-surgery-study/2473421/For patients who experience massive weight loss after bariatric surgery, subsequent body contouring to remove excess skin is not itself associated with long-term weight loss, reports a
- Radiofrequency Microneedling: Optimize Your Resultshttps://modernaesthetics.com/news/radiofrequency-microneedling-optimize-your-results/2473417/For optimal results when treating patients with radiofrequency (RF) microneedling, anecdotal and personal experience guide Elizabeth L. Tanzi, MD, as there are “No significant comparison studies to date” on the
- Microneedling Plus Cupping May Aid Skin Rejuvenationhttps://modernaesthetics.com/news/microneedling-plus-cupping-may-aid-skin-rejuvenation/2473420/Microneedling to induce collagen and cupping to increase tissue perfusion may have a synergistic effect on skin rejuvenation, according to an experimental study in the June issue of Plastic and Reconstructive Surgery. "Cupping therapy can be added to microneedling therap
- FDA Approves Skinvive by Juvéderm to Improve Skin Smoothness in Cheekshttps://modernaesthetics.com/news/fda-approves-skinvive-by-juvederm-to-improve-skin-smoothness-in-cheeks/2473415/The U.S. Food and Drug Administration gave its nod to Skinvive by Juvéderm to improve skin smoothness of the cheeks in adults over the age of 21. Skinvive by Juvéderm is the first and only hyaluronic acid (HA) intradermal microdroplet injection for skin smoothness availabl
- Cutera Update: Agreements Made with Pura Vida and RTW; New Board Members Appointedhttps://modernaesthetics.com/news/cutera-update-agreements-with-pura-vida-and-rtw/2473414/Cutera announced that it has entered into cooperation agreements with two of its largest stockholders, Pura Vida Investments LLC and RTW Investments LP, which collectively own more than 15% of the company’s outstanding shares. Pursuant to the agreements, Cutera will appo
- Analysis: Millennials Drive Spending Growth in a Post-COVID Aesthetics Industryhttps://modernaesthetics.com/news/analysis-millennials-drive-spending-growth-in-a-post-covid-aesthetics-industry/2473413/The aesthetics industry is undergoing a swift transformation. Analysis of data from the last 5 years paints a clear picture of a post-pandemic shift in how the industry is addressing changing demand and the needs of a rapidly evolving customer base, according to market intelligence prov
- Dr. Shiv Sabesan Named CTO at Cytrellishttps://modernaesthetics.com/news/dr-shiv-sabesan-named-cto-at-cytrellis/2473409/Dr. Shiv Sabesan is Cytrellis Biosystems’ Chief Technology Officer. In his new role, Dr. Sabesan will lead the company's strategy as it continues to advance its proprietary ellacor Micro-Coring technology and expand indications. The technology was